AzTrials
AzTrials

Alternative Smoking ProductsNCT04302480

A Brief Intervention Programme on ASP

A study testing Worksheets for ASP, Worksheets for SSB and E-messages for ASP in people with Alternative Smoking Products, run by The University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The brief intervention comprises a 4-page worksheet used in the classroom (main intervention) and subsequent weekly e-messages through WhatsApp (booster intervention). The worksheets for both groups will be printed in colour, and mainly contain pictures and simple texts. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Alternative Smoking Products
What is being tested?
Worksheets for ASP, Worksheets for SSB and E-messages for ASP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000 participants
Where
1 siteHong Kong
Study dates
18 May 2020to 31 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Parents and children should understand Chinese.
  • Parents' consent to their children's participation.

Who cannot join

  • N/A

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Local primary schools

    Hong Kong

Other trials in Hong Kong

About this study

Official title: A Brief Intervention Programme on Alternative Smoking Products

The brief intervention comprises a 4-page worksheet used in the classroom (main intervention) and subsequent weekly e-messages through WhatsApp (booster intervention). The worksheets for both groups will be printed in colour, and mainly contain pictures and simple texts. Students will be asked to provide smartphone numbers of themselves and their parents for receiving the booster interventions. After sending 4-6 e-messages in 4 weeks, students will complete a 1-month follow-up assessment.

Being tested
Worksheets for ASP, Worksheets for SSB, E-messages for ASP, E-messages for SSB

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Worksheets for ASPOther

    The ASP intervention will cover the harms and misleading marketing strategies of ASPs and other related information.

  • Worksheets for SSBOther

    The SSB intervention will cover the general information on SSBs, such as the sugar content of SSBs, nutrition labels and the harms of SSBs.

  • E-messages for ASPOther

    In the subsequent month after the main intervention, students in the ASP group will receive 4-6 e-messages on ASPs, after which students will be invited to complete a 1-month follow-up assessment.

  • E-messages for SSBOther

    In the subsequent month after the main intervention, students in the SSB group will receive 4-6 e-messages on SSBs, after which students will be invited to complete a 1-month follow-up assessment.

Study groups in NCT04302480
Study groupRoleWhat they receive
Alternative smoking products (ASP)ExperimentalNot described
Receives: Other: Worksheets for ASP; Other: E-messages for ASP
Sugar-sweetened beverages (SSB)Active comparatorNot described
Receives: Other: Worksheets for SSB; Other: E-messages for SSB

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knowledge on the harms and misleading marketing strategies of ASPs

    Students will report their opinions towards 5 statements:

    1. Children who use e-cigarettes are more likely to smoke cigarettes in the future;
    2. Hazards of secondhand smoke of e-cigarettes and heated tobacco products are slight;
    3. Nicotine content in heated tobacco products is lower than in the cigarettes, which is more difficult to get addicted;
    4. There are a variety of carcinogens in the heated tobacco products;
    5. Tobacco industries do everything they can to get young people to use tobacco products.

    All the statements have 5 options from definitely no to definitely yes. The options will be recoded into 0-4 or 4-0, as appropriate, with higher scores indicating knowing more about the harms and misleading marketing strategies of ASPs.

    Measured: Immediately after intervention

  2. Attitudes towards ASPs

    Students will report their opinions towards 2 questions:

    1. Do you think the usage of e-cigarettes and heated tobacco products will harm your health? There will be 11 options from definitely no harm to definitely harm.
    2. Do you accept the primary students use e-cigarettes and heated tobacco products?

    There will be 11 options from definitely unacceptable to definitely acceptable.

    Measured: Immediately after intervention

Secondary outcomes (4)
  1. Intention to use ASPs

    If one of your good friends offers you an e-cigarette or heated tobacco product, ask you to have a few puffs, and no one will know about this as no more smoking in the future. Will you use them?

    There will be 11 options from definitely no to definitely yes.

    Measured: Immediately after intervention

  2. Knowledge on the harms and misleading marketing strategies of ASPs

    Students will report their opinions towards 5 statements:

    1. Hazards of e-cigarettes are slight, can only cause minor health problems;
    2. Reliable evidence shows that e-cigarettes can help quit smoking cigarettes;
    3. Heated tobacco products contain tar, can cause a variety of cancers;
    4. Heated tobacco products are harm reduction products, which is less harmful than cigarettes;
    5. Tobacco industries conceal the harms of tobacco products for commercial gain.

    All the statements have 5 options from definitely no to definitely yes. The options will be recoded into 0-4 or 4-0, as appropriate, with higher scores indicating knowing more about the harms and misleading marketing strategies of ASPs.

    Measured: 1-month follow-up

  3. Attitudes towards ASPs

    Students will report their opinions towards 2 questions:

    1. Do you think the usage of e-cigarettes and heated tobacco products will harm your health? There will be 11 options from definitely no harm to definitely harm.
    2. Do you accept the primary students use e-cigarettes and heated tobacco products?

    There will be 11 options from definitely unacceptable to definitely acceptable.

    Measured: 1-month follow-up

  4. Intention to use ASPs

    If one of your good friends offers you an e-cigarette or heated tobacco product, ask you to have a few puffs, and no one will know about this as no more smoking in the future. Will you use them?

    There will be 11 options from definitely no to definitely yes.

    Measured: 1-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2020
  2. Study start18 May 2020 (estimated)
  3. Primary completion31 Jul 2020 (estimated)
  4. Study completion31 Jul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04302480
Sponsor's protocol ID
coshdrama2020
Status last verified
Mar 2020
First submitted
6 Mar 2020
Last updated
10 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Worksheets for ASP, Worksheets for SSB and E-messages for ASP in people with Alternative Smoking Products, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tingting Chen, MS (51657486 ext. 852, phttchen@connect.hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knowledge on the harms and misleading marketing strategies of ASPs (time frame: Immediately after intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2020; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in